271 related articles for article (PubMed ID: 12520711)
1. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
[TBL] [Abstract][Full Text] [Related]
2. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
4. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM
Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
[TBL] [Abstract][Full Text] [Related]
5. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
6. Trisomy 8 in prefibrotic early stages of chronic idiopathic myelofibrosis: a fluorescence in situ study of bone marrow biopsies.
Thiele J; Varus E; Kvasnicka HM; Wickenhauser C
Acta Haematol; 2006; 115(1-2):97-101. PubMed ID: 16424657
[TBL] [Abstract][Full Text] [Related]
7. [Study of 161 chronic idiopathic myelofibrosis patients for clinicopathological staging].
Liu AN; Chen HS; Liu EB; Fang LH; Yang QY; Qian LS
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):178-82. PubMed ID: 16792920
[TBL] [Abstract][Full Text] [Related]
8. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
9. Hematopathologic findings in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM
Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case].
Uemura Y; Iwahara Y; Kataoka R; Muneishi H; Miyoshi I
Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Schmitt-Gräff A; Hülsemann R; Diehl V
Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
Thiele J; Kvasnicka HM; Vardiman J
Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
[TBL] [Abstract][Full Text] [Related]
13. Prefibrotic chronic idiopathic myelofibrosis--a diagnostic enigma?
Thiele J; Kvasnicka HM
Acta Haematol; 2004; 111(3):155-9. PubMed ID: 15034237
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
Thiele J; Kvasnicka HM
Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
[TBL] [Abstract][Full Text] [Related]
15. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC
Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)].
Hernandez Nieto L; Morey Sureda M; Granena A; Montserrat Costa E; Feliu E; Rozman C
Nouv Rev Fr Hematol (1978); 1979; 21(3):251-6. PubMed ID: 296376
[TBL] [Abstract][Full Text] [Related]
17. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
18. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
19. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
Hasselbalch HC; Bjerrum OW; Jensen BA; Clausen NT; Hansen PB; Birgens H; Therkildsen MH; Ralfkiaer E
Am J Hematol; 2003 Dec; 74(4):238-42. PubMed ID: 14635203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]